Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Creating synergy in our health system: The challenges of primary angioplasty.

× No keyword cloud information.

15 in total

1. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Authors: Philippe Gabriel Steg; Eric Bonnefoy; Sylvie Chabaud; Frédéric Lapostolle; Pierre-Yves Dubien; Pascal Cristofini; Alain Leizorovicz; Paul Touboul
Journal: Circulation Date: 2003-11-17 Impact factor: 29.690

2. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy.

Authors: Jean-Philippe Collet; Gilles Montalescot; Michel Le May; Maria Borentain; Anthony Gershlick
Journal: J Am Coll Cardiol Date: 2006-09-14 Impact factor: 24.094

3. Thrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General Hospital.

Authors: S P Janda; N Tan
Journal: Can J Cardiol Date: 2009-11 Impact factor: 5.223

4. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.

Authors: Marc S Sabatine; David A Morrow; Gilles Montalescot; Mikael Dellborg; Jose L Leiva-Pons; Matyas Keltai; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Journal: Circulation Date: 2005-11-15 Impact factor: 29.690

5. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.

Authors: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; P Gabriel Steg; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Journal: JAMA Date: 2002-11-06 Impact factor: 56.272

6. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors: D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal: Circulation Date: 2000-05-16 Impact factor: 29.690

7. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.

Authors: Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Journal: Circulation Date: 2006-10-30 Impact factor: 29.690

Review 8. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors: Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal: Lancet Date: 2003-01-04 Impact factor: 79.321

9. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.

Authors: Eric Boersma
Journal: Eur Heart J Date: 2006-03-02 Impact factor: 29.983

10. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors: M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal: Circulation Date: 2003-10-06 Impact factor: 29.690